MLYS NASDAQ
Mineralys Therapeutics, Inc.
1W: +10.8%
1M: +4.5%
3M: +8.4%
YTD: -15.3%
1Y: +87.8%
3Y: +93.2%
$29.85
-0.38 (-1.26%)
Weekly Expected Move ±8.2%
$23
$25
$27
$30
$32
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
🏦 Institutional Activity
Latest: Q1 2026253
Institutions Holding
+5 vs prior
117.2%
Ownership
-61.24%
28
New
84
Increased
111
Reduced
68
Closed
👔 Insider Trades
25 records| Date | Name | Title | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-18 | Rodman David Malcom | officer: chief medical officer | S-Sale | 417 | $27.55 | $11K | Filing |
| 2026-05-13 | Rodman David Malcom | officer: chief medical officer | S-Sale | 14,056 | $28.58 | $402K | Filing |
| 2026-05-12 | Rodman David Malcom | officer: chief medical officer | S-Sale | 6,348 | $29.36 | $186K | Filing |
| 2026-05-11 | Rodman David Malcom | officer: chief medical officer | S-Sale | 2,171 | $29.71 | $65K | Filing |
| 2026-04-17 | Rodman David Malcom | officer: chief medical officer | S-Sale | 416 | $31.33 | $13K | Filing |
| 2026-04-15 | Rodman David Malcom | officer: chief medical officer | S-Sale | 6,348 | $27.66 | $176K | Filing |
| 2026-04-13 | Congleton Jon | officer: chief executive officer | S-Sale | 15,730 | $26.83 | $422K | Filing |
| 2026-04-13 | Rodman David Malcom | officer: chief medical officer | S-Sale | 14,058 | $26.54 | $373K | Filing |
| 2026-04-09 | Rodman David Malcom | officer: chief medical officer | S-Sale | 2,170 | $27.38 | $59K | Filing |
| 2026-03-31 | Congleton Jon | officer: chief executive officer | S-Sale | 19,364 | $25.50 | $494K | Filing |
| 2026-03-31 | Congleton Jon | officer: chief executive officer | S-Sale | 55,183 | $26.54 | $1.5M | Filing |
| 2026-03-31 | Congleton Jon | officer: chief executive officer | S-Sale | 453 | $27.05 | $12K | Filing |
| 2026-03-31 | Karydas Daphne | director | S-Sale | 3,000 | $25.00 | $75K | Filing |
| 2026-03-30 | Kolchinsky Peter | director | P-Purchase | 58,300 | $24.16 | $1.4M | Filing |
| 2026-03-30 | Shah Rajeev M. | director | P-Purchase | 58,300 | $24.16 | $1.4M | Filing |
| 2026-03-30 | RA Capital Nexus Fund III, L.P. | director | P-Purchase | 58,300 | $24.16 | $1.4M | Filing |
| 2026-03-30 | RA Capital Healthcare Fund LP | director | P-Purchase | 58,300 | $24.16 | $1.4M | Filing |
| 2026-03-30 | RA CAPITAL MANAGEMENT, L.P. | director | P-Purchase | 58,300 | $24.16 | $1.4M | Filing |
| 2026-03-27 | RA CAPITAL MANAGEMENT, L.P. | director | P-Purchase | 310,700 | $23.67 | $7.4M | Filing |
| 2026-03-27 | Shah Rajeev M. | director | P-Purchase | 310,700 | $23.67 | $7.4M | Filing |
| 2026-03-27 | Kolchinsky Peter | director | P-Purchase | 310,700 | $23.67 | $7.4M | Filing |
| 2026-03-27 | RA Capital Nexus Fund III, L.P. | director | P-Purchase | 310,700 | $23.67 | $7.4M | Filing |
| 2026-03-27 | RA Capital Healthcare Fund LP | director | P-Purchase | 310,700 | $23.67 | $7.4M | Filing |
| 2026-03-13 | Rodman David Malcom | officer: chief medical officer | S-Sale | 253 | $27.82 | $7K | Filing |
| 2026-03-13 | Rodman David Malcom | officer: chief medical officer | S-Sale | 10,726 | $25.91 | $278K | Filing |
🏛️ Congressional Trades
0 records| Date | Politician | Chamber | Type | Amount | Filing |
|---|---|---|---|---|---|
| No congressional trades found | |||||
🏦 Top Institutional Holders
20 holders| Holder | Shares | Value | Date Reported | Filing | |
|---|---|---|---|---|---|
| Lion Point Capital, LP | 10,500 | $284M | — | 2026-03-31 | Filing |
| Catalys Pacific, LLC | 7,903,838 | $214M | — | 2026-03-31 | Filing |
| RA CAPITAL MANAGEMENT, L.P. | 7,692,750 | $208M | +369,000 | 2026-03-31 | Filing |
| FMR LLC | 4,861,104 | $132M | -196,405 | 2026-03-31 | Filing |
| BlackRock, Inc. | 4,481,582 | $121M | +153,904 | 2026-03-31 | Filing |
| WELLINGTON MANAGEMENT GROUP LLP | 3,359,068 | $91M | +2,574,801 | 2026-03-31 | Filing |
| STATE STREET CORP | 2,935,940 | $80M | -249,059 | 2026-03-31 | Filing |
| Caligan Partners LP | 2,772,654 | $75M | — | 2026-03-31 | Filing |
| VANGUARD CAPITAL MANAGEMENT LLC | 2,454,363 | $66M | +2,454,363 | 2026-03-31 | Filing |
| Laurion Capital Management LP | 2,232,040 | $60M | +518,555 | 2026-03-31 | Filing |
| ORBIMED ADVISORS LLC | 2,052,900 | $56M | +1,072,500 | 2026-03-31 | Filing |
| Point72 Asset Management, L.P. | 1,911,433 | $52M | +704,213 | 2026-03-31 | Filing |
| FRANKLIN RESOURCES INC | 1,784,662 | $48M | -4,085 | 2026-03-31 | Filing |
| ANDERA PARTNERS | 1,591,917 | $43M | — | 2026-03-31 | Filing |
| SR One Capital Management, LP | 1,563,966 | $42M | — | 2026-03-31 | Filing |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,538,662 | $42M | — | 2026-03-31 | Filing |
| Polar Capital Holdings Plc | 1,500,749 | $41M | +99,608 | 2026-03-31 | Filing |
| GEODE CAPITAL MANAGEMENT, LLC | 1,301,135 | $35M | +43,553 | 2026-03-31 | Filing |
| JENNISON ASSOCIATES LLC | 1,266,174 | $34M | +7,521 | 2026-03-31 | Filing |
| ARMISTICE CAPITAL, LLC | 1,176,000 | $32M | +499,965 | 2026-03-31 | Filing |